These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36285653)

  • 1. Evaluation of propylene glycol methyl ether as a potential challenge agent for leak detection of liquid and headspace from closed system drug transfer devices using Fourier transform infrared spectroscopy.
    Westbrook EG; Doepke A; Streicher RP
    Anal Methods; 2022 Nov; 14(43):4393-4407. PubMed ID: 36285653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance testing protocol for closed-system transfer devices used during pharmacy compounding and administration of hazardous drugs.
    Wilkinson AS; Allwood MC; Morris CP; Wallace A; Finnis R; Kaminska E; Stonkute D; Szramowska M; Miller J; Pengelly I; Hemingway M
    PLoS One; 2018; 13(10):e0205263. PubMed ID: 30379831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Source apportionment and quantification of liquid and headspace leaks from closed system drug-transfer devices via Selected Ion Flow Tube Mass Spectrometry (SIFT-MS).
    Doepke A; Streicher RP
    PLoS One; 2021; 16(11):e0258425. PubMed ID: 34735484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Six Commercially Available Closed-System Drug-Transfer Devices Against NIOSH's 2015 Draft Vapor Protocol.
    Halloush S; Reveles IA; Koeller J
    Hosp Pharm; 2020 Dec; 55(6):391-399. PubMed ID: 33245720
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of three barrier-type closed system transfer devices using the 2015 NIOSH vapor containment performance draft protocol.
    Szkiladz A; Hegner S
    Drugs Ther Perspect; 2022; 38(4):177-184. PubMed ID: 35313703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the 2015 proposed NIOSH vapor containment performance protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs.
    Forshay CM; Streeter SO; Salch SA; Eckel SF
    J Oncol Pharm Pract; 2019 Jul; 25(5):1160-1166. PubMed ID: 30041583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propylene glycol monomethyl ether occupational exposure. 3. Exposure of human volunteers.
    Devanthéry A; Berode M; Droz PO
    Int Arch Occup Environ Health; 2002 Apr; 75(4):203-8. PubMed ID: 11981652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic occupational exposure to organic solvents. XV. Glycol ether exposure during the manufacture of brakehoses.
    Hubner B; Lehnert G; Schaller KH; Welte D; Angerer J
    Int Arch Occup Environ Health; 1992; 64(4):261-4. PubMed ID: 1468795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis kinetics of propylene glycol monomethyl ether acetate in rats in vivo and in rat and human tissues in vitro.
    Domoradzki JY; Brzak KA; Thornton CM
    Toxicol Sci; 2003 Sep; 75(1):31-9. PubMed ID: 12857936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-weighted average sampling of airborne propylene glycol ethers by a solid-phase microextraction device.
    Shih HC; Tsai SW; Kuo CH
    J Occup Environ Hyg; 2012; 9(7):427-36. PubMed ID: 22651222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on toxicokinetics among human volunteers exposed to propylene glycol methyl ether (PGME).
    Hopf NB; Vernez D; Berthet A; Charriere N; Arnoux C; Tomicic C
    Toxicol Lett; 2012 May; 211(1):77-84. PubMed ID: 22421272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylene glycol monomethyl ether (PGME) occupational exposure. 1. Biomonitoring by analysis of PGME in urine.
    Devanthéry A; Dentan A; Berode M; Droz PO
    Int Arch Occup Environ Health; 2000 Jul; 73(5):311-5. PubMed ID: 10963414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-Sensitive Aspects of Mars Sample Return (MSR) Science.
    Tosca NJ; Agee CB; Cockell CS; Glavin DP; Hutzler A; Marty B; McCubbin FM; Regberg AB; Velbel MA; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Pratt LM; Smith AL; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Wadhwa M; Westall F; Zorzano MP
    Astrobiology; 2022 Jun; 22(S1):S81-S111. PubMed ID: 34904889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting human neurotoxicity of propylene glycol methyl ether (PGME) by implementing in vitro neurotoxicity results into toxicokinetic modelling.
    Reale E; Sandstrom J; Culot M; Hechon J; Wellens S; Heymans M; Tschudi-Monnet F; Vernez D; Hopf NB
    Sci Total Environ; 2023 Aug; 886():163767. PubMed ID: 37156387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of 1-methoxy-2-propanol and its metabolite 1,2-propanediol in rat and mouse plasma by gas chromatography.
    Ferrala NF; Ghanayem BI; Nomeir AA
    J Chromatogr B Biomed Appl; 1994 Oct; 660(2):291-6. PubMed ID: 7866519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear kinetics of inhaled propylene glycol monomethyl ether in Fischer 344 rats following single and repeated exposures.
    Morgott DA; Nolan RJ
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):19-28. PubMed ID: 3109074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Different Quality-Relevant Aspects of Closed System Transfer Devices (CSTDs).
    Besheer A; Mahler HC; Matter-Schwald A; Barrenechea SM; Vogt M; Chalus P; Heymes P; Pillow T; Kirste A; Favrod P; Joerg S; Mathaes R
    Pharm Res; 2020 Apr; 37(4):81. PubMed ID: 32274594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device.
    Levin G; Sessink PJ
    J Oncol Pharm Pract; 2022 Oct; 28(7):1508-1515. PubMed ID: 34229499
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.